I am a neuroscientist fully dedicated to understand neurodegenerative disorders with special emphasis in Alzheimer’s disease. Since, Neurology and aging research are areas poorly developed in Latin America countries, I have focused my work to Alzheimer's disease and dementia affecting this particular population contributing to diminish the mayor economical and social costs associated to brain health disorders. My research and academic interests are aligned to provide a useful platform to generate new knowledge and link basic and clinical research, promoting high translational discoveries and clinical collaborations. My projects encourage the consolidation of a research group to study the neuropathological, clinical and translational research in Alzheimer´s disease. I am also interested in global studies to validate novel biomarkers for early diagnosis and therapies to treat this neurodegenerative and age-related disorder. Currently, I am co-Director of Latin American Brain Health Institute (BrainLat) at Universidad Adolfo Ibáñez (UAI) and I am also involved to regional initiatives, such as the Multi-partner consortium to expand dementia research in Latin America (ReDLat) and the Latin American and Caribbean Consortium on Dementia (LAC-CD). According to my career and personal goals, in addition to study and contribute with the knowledge of Alzheimer’s disease, I am also lead the scientific committee of the Chilean Alzheimer’s corporation COPRAD, an association that’s searches improving the quality of life of AD patients, and provide information to patient and family members about current treatment efforts and what it means to develop Alzheimer’s.

Dementia, Biomarkers, Neurodegeneration, Amyloid Proteins, Alzheimer Disease.

Bachelor of Science, Major in Biology, Universidad de Chile 2006